Our data also showed that low expression of TET1 or FOXO4 predicts poor survival of gastric cancer patients, suggesting that reactivation of TET1 or FOXO4 might be a novel therapeutic approach to prevent gastric cancer metastasis. The gene discussed is FOXO4; the disease is gastric cancer.